{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:45:02Z","timestamp":1791387902062,"version":"4.3.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006546","name":"Angelini Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10096-016-2845-z","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T12:30:06Z","timestamp":1480336206000},"page":"677-680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)"],"prefix":"10.1007","volume":"36","author":[{"given":"D.","family":"Knafl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tobudic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. R.","family":"Bellamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Thalhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"2845_CR1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro821","volume":"2","author":"L Hall-Stoodley","year":"2004","unstructured":"Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95\u2013108","journal-title":"Nat Rev Microbiol"},{"key":"2845_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3201\/eid0702.010226","volume":"7","author":"RM Donlan","year":"2001","unstructured":"Donlan RM (2001) Biofilms and device-associated infections. Emerg Infect Dis 7:277\u2013281","journal-title":"Emerg Infect Dis"},{"key":"2845_CR3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.micro.57.030502.090720","volume":"57","author":"MR Parsek","year":"2003","unstructured":"Parsek MR, Singh PK (2003) Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57:677\u2013701","journal-title":"Annu Rev Microbiol"},{"issue":"4","key":"2845_CR4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1017\/ice.2015.323","volume":"37","author":"AE Simor","year":"2016","unstructured":"Simor AE, Pelude L, Golding G (2016) Determinants of outcome in hospitalized patients with methicillin-resistant Staphylococcus aureus bloodstream infection: results from national surveillance in Canada, 2008\u20132012. Infect Control Hosp Epidemiol37(4):390\u2013397","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2845_CR5","doi-asserted-by":"crossref","unstructured":"Zajonz D, Wuthe L, Rodloff AC et al (2015) Infections of hip and knee endoprotheses: spectrum of pathogens and the role of multiresistant bacteria. Chirurg 87(4):332\u2013339 [Article in German]","DOI":"10.1007\/s00104-015-0126-5"},{"key":"2845_CR6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/379015","volume":"37","author":"E Seltzer","year":"2003","unstructured":"Seltzer E, Dorr MB, Goldstein BP et al (2003) Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections. Clin Infect Dis 37:1298\u20131303","journal-title":"Clin Infect Dis"},{"key":"2845_CR7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijantimicag.2013.05.019","volume":"42","author":"D Baldoni","year":"2013","unstructured":"Baldoni D, Furustrand Tafin U, Aeppli S et al (2013) Activity of dalbavancin, alone and in combination with rifampicin, against methicillin-resistant Staphylococcus Aureus in a foreign-body infection model. Int J Antimicrob Agents 42:220\u2013225","journal-title":"Int J Antimicrob Agents"},{"key":"2845_CR8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1086\/427283","volume":"40","author":"I Raad","year":"2005","unstructured":"Raad I, Darouiche R, Vazquez J et al (2005) Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens. Clin Infect Dis 40:374\u2013380","journal-title":"Clin Infect Dis"},{"key":"2845_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diagmicrobio.2003.09.004","volume":"48","author":"JM Streit","year":"2004","unstructured":"Streit JM, Fritsche TR, Sader HS et al (2004) Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates. Diagn Microbiol Infect 48:137\u2013143","journal-title":"Diagn Microbiol Infect"},{"key":"2845_CR10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/IAI.37.1.318-326.1982","volume":"37","author":"GD Christensen","year":"1982","unstructured":"Christensen GD, Simpson WA, Bisno AL et al (1982) Adherence of slime-producing strains of Staphylococcus Epidermidis to smooth surfaces. Infect Immun 37:318\u2013326","journal-title":"Infect Immun"},{"key":"2845_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/antibiotics3030378","volume":"3","author":"J Nowakowska","year":"2014","unstructured":"Nowakowska J, Landmann R, Khanna N (2014) Foreign body infection models to study host-pathogen response and antimicrobial tolerance of bacterial biofilm. Antibiotics 3:378\u2013397. doi: 10.3390\/antibiotics3030378","journal-title":"Antibiotics"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2845-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2845-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2845-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T15:04:41Z","timestamp":1601219081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2845-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["2845"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2845-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]}}}